- Home
- Publications
- Publication Search
- Publication Details
Title
How I treat plasma cell leukemia
Authors
Keywords
-
Journal
BLOOD
Volume 120, Issue 12, Pages 2376-2389
Publisher
American Society of Hematology
Online
2012-07-28
DOI
10.1182/blood-2012-05-408682
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Flow cytometric immunophenotypic characteristics of plasma cell leukemia
- (2013) Maria Kraj et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- IMWG consensus on maintenance therapy in multiple myeloma
- (2012) H. Ludwig et al. BLOOD
- Primary plasma cell leukemia: a retrospective multicenter study of 73 patients
- (2011) L. Pagano et al. ANNALS OF ONCOLOGY
- Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party
- (2011) G. D'Arena et al. ANNALS OF ONCOLOGY
- High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma
- (2011) B. Paiva et al. BLOOD
- Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p
- (2011) K. Neben et al. BLOOD
- The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis
- (2011) G. J. Morgan et al. BLOOD
- Clinical Outcomes of Patients With Plasma Cell Leukemia in the Era of Novel Therapies and Hematopoietic Stem Cell Transplantation Strategies: A Single-Institution Experience
- (2011) Daniel Lebovic et al. Clinical Lymphoma Myeloma & Leukemia
- Chromosome abnormalities defined by conventional cytogenetics in plasma cell leukemia: what have we learned about its biology?
- (2011) Victor H. Jimenez-Zepeda et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research
- (2011) A Mahindra et al. LEUKEMIA
- Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience
- (2011) H Avet-Loiseau et al. LEUKEMIA
- Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen
- (2010) Edward Libby et al. AMERICAN JOURNAL OF HEMATOLOGY
- Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma
- (2010) B. A. Walker et al. BLOOD
- correspondence: CD23 expression in plasma cell leukaemia
- (2010) Gabriele Buda et al. BRITISH JOURNAL OF HAEMATOLOGY
- CD23 expression in plasma cell myeloma is specific for abnormalities of chromosome 11, and is associated with primary plasma cell leukaemia in this cytogenetic sub-group
- (2010) Matthew Walters et al. BRITISH JOURNAL OF HAEMATOLOGY
- Treatment of relapsed and refractory multiple myeloma in the era of novel agents
- (2010) Niels W.C.J. van de Donk et al. CANCER TREATMENT REVIEWS
- Primary plasma cell leukemia and autologous stem cell transplantation
- (2010) M. B. Drake et al. HAEMATOLOGICA
- Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p)
- (2010) Hervé Avet-Loiseau et al. JOURNAL OF CLINICAL ONCOLOGY
- Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma
- (2010) Marco Ladetto et al. JOURNAL OF CLINICAL ONCOLOGY
- Flow cytometric immunophenotypic characteristics of 36 cases of plasma cell leukemia
- (2010) Maria Kraj et al. LEUKEMIA RESEARCH
- 1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma
- (2009) H Chang et al. BONE MARROW TRANSPLANTATION
- TP53deletion is not an adverse feature in multiple myeloma treated with total therapy 3
- (2009) John D. Shaughnessy et al. BRITISH JOURNAL OF HAEMATOLOGY
- Primary plasma cell leukemia
- (2009) Giridharan Ramsingh et al. CANCER
- Frequent upregulation ofMYCin plasma cell leukemia
- (2009) Laura Chiecchio et al. GENES CHROMOSOMES & CANCER
- Prognostic Significance of Copy-Number Alterations in Multiple Myeloma
- (2009) Hervé Avet-Loiseau et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenalidomide, Melphalan, and Prednisone Association Is an Effective Salvage Therapy in Relapsed Plasma Cell Leukaemia
- (2009) Tommasina Guglielmelli et al. Journal of Oncology
- Genetic aberrations and survival in plasma cell leukemia
- (2008) R E Tiedemann et al. LEUKEMIA
- Bortezomib, doxorubicin and dexamethasone association is an effective option for plasma cell leukemia induction therapy
- (2008) Chadi Al-Nawakil et al. LEUKEMIA & LYMPHOMA
- Salvage therapy with lenalidomide and dexamethasone in relapsed primary plasma cell leukemia
- (2008) Pellegrino Musto et al. LEUKEMIA RESEARCH
- Response of primary plasma cell leukemia to the combination of bortezomib and dexamethasone: Do specific cytogenetic and immunophenotypic characteristics influence treatment outcome?
- (2008) Eirini Katodritou et al. LEUKEMIA RESEARCH
- Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia
- (2008) Hong Chang et al. LEUKEMIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More